N/A N=24 Randomized Single-blind Treatment

New Therapeutical Perspectives in Cases of Phonological Disorders

Speech Sound Disorders

Bottom Line

View on ClinicalTrials.gov: NCT02935062 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2019

Primary outcome: Primary: Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument — 70.63; 68.13; 75.5; 79.88 PCC - (%) — p=0.001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Traditional Phonological Therapy (Behavioral); Software Phonological Therapy- SIFALA (Behavioral); Placebo Therapy (Behavioral)
Age: Pediatric · 4+ yrs
Sex: All
Sponsor: Universidade Federal de Santa Maria
Primary completion: Feb 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Consonants Correct (PCC) Pre-treatment and Post-treatment Phonological Instrument	70.63; 68.13; 75.5; 79.88; 80.63; 82.88	0.001 sig
PRIMARY P300- Long-latency Auditory Evoked Potential	383.60; 373.28; 357.33; 344.00; 362.66; 353.23	0.011 sig

Summary

The aim of this study is to verify phonological and auditory aspects of children submitted to traditional phonological therapy, phonological therapy using a software and placebo therapy in children with phonological disorders.

Eligibility Criteria

Inclusion Criteria

Parents/guardians and child agree to participate and have signed the Informed Consent Form;
Have age between 4: 0 to 8:11 (years:months);
Present diagnosis of phonological disorders;
Present hearing thresholds within the normal range

Exclusion Criteria

Present neurological impairment, emotional and/or cognitive clearly diagnosed, or have complaint;
Present any degree of hearing loss is the type conductive, mixed or sensorineural, and middle ear disorders in time of selection, as well as having presented otitis complaints;
Present language impairment associated with speech sound disorder;
Present commitment in the stomatognathic system that can interfere in the speech production;
Have been received speech and language therapy before.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02935062). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.